NHS framework for Lenvatinib supply across three regional lots.
NHS England is establishing a national framework agreement for the supply of Lenvatinib, a pharmaceutical product. The framework is divided into three lots covering different regions: Lot 1 (CESW) from June 2027 to January 2029 (20 months), Lot 2 (NWLN) from June 2027 to September 2028 (16 months), and Lot 3 (LSNE) from June 2027 to May 2028 (12 months). The framework may be extended up to an additional 24 months at the discretion of the authority. The buyer is the Medicines Procurement and Supply Chain division of NHS England. This notice is for a pharmaceutical supply framework, likely requiring relevant manufacturing and supply certifications.